Current status of non-viral gene therapy for CNS disorders.
about
Novel biodegradable nanocarriers for enhanced drug delivery.Transfection of primary brain capillary endothelial cells for protein synthesis and secretion of recombinant erythropoietin: a strategy to enable protein delivery to the brain.Advancements in nano-enabled therapeutics for neuroHIV management.Development of magneto-plasmonic nanoparticles for multimodal image-guided therapy to the brain.Effects of spinal non-viral interleukin-10 gene therapy formulated with d-mannose in neuropathic interleukin-10 deficient mice: Behavioral characterization, mRNA and protein analysis in pain relevant tissues.
P2860
Current status of non-viral gene therapy for CNS disorders.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Current status of non-viral gene therapy for CNS disorders.
@ast
Current status of non-viral gene therapy for CNS disorders.
@en
type
label
Current status of non-viral gene therapy for CNS disorders.
@ast
Current status of non-viral gene therapy for CNS disorders.
@en
prefLabel
Current status of non-viral gene therapy for CNS disorders.
@ast
Current status of non-viral gene therapy for CNS disorders.
@en
P2093
P2860
P50
P1476
Current status of non-viral gene therapy for CNS disorders.
@en
P2093
Arti Vashist
Daniela Sosa
Madhavan Nair
P2860
P304
P356
10.1080/17425247.2016.1188802
P407
P577
2016-06-01T00:00:00Z